Clinical trial
PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) A Multicenter, Prospective, Cohort Study To Assess The Genomic Profiles And Associated Therapy Decision In Gastrointestinal Cancer
NCT04484636 is registered in ClinicalTrials.gov with Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) A Multicenter, Prospective, Cohort Study To Assess The Genomic Profiles And Associated Therapy Decision In Gastrointestinal Cancer
- Lead sponsor
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 28, 2020
- Completion date
- December 31, 2024
- Enrollment
- 400 (actual)
- Sites
- 46
Conditions
As the registry lists them; a condition with its own page is linked.
cholangiocarcinoma, gallbladder cancer, hepatocellular cancer, oesophageal cancer, pancreatic cancer, stomach cancer